Characteristics of Benign and Malignant Neoplasms — MCQs
What is the earliest change of neoplastic transformation observed at the microscopic level?
Anaplasia in Wilms' tumor is evident by what features?
Which of the following is true about Anaplasia?
Which of the following features on mammogram would suggest malignancy?
Which malignancy is characterized by a stepwise progression through lymph nodes, making staging an important prognostic factor?
Which of the following stages of lip carcinoma does not have nodal involvement?
Which of the following is not a characteristic of malignant lesions?
Which of the following has the least malignant potential?
Best marker for distinguishing reactive from neoplastic mesothelial proliferation?
Regarding parotid neoplasms, the false statement is
Characteristics of Benign and Malignant Neoplasms Indian Medical PG Practice Questions and MCQs
Question 1: What is the earliest change of neoplastic transformation observed at the microscopic level?
- A. Dysplasia (Correct Answer)
- B. Atypical Hyperplasia
- C. Invasive Carcinoma
- D. Squamous Metaplasia
Explanation: ***Dysplasia*** - Dysplasia represents the **earliest microscopic changes** in neoplastic transformation, indicating **abnormal growth** or development of cells [1,4]. - It is characterized by changes in **cell shape, size, and organization**, often seen before the development of invasive cancer [1]. *Metaplasia* - Metaplasia involves the **replacement of one differentiated cell type** with another, often as an adaptation to chronic irritation or injury [1]. - While it can be a precursor to dysplasia, it does not represent the **initial cellular changes** indicative of neoplastic transformation. *Carcinoma insitu* - Carcinoma insitu represents a more advanced pre-invasive stage where abnormal cells are present but have not invaded **surrounding tissues** [3]. - It occurs after dysplastic changes and signifies a higher level of malignancy, not the **earliest changes** [3]. *Hyperplasia* - Hyperplasia is characterized by an **increase in the number of cells** but typically maintains normal cell structure and function [1]. - It is a reactive process and does not indicate neoplastic transformation, which is marked by **cellular atypia** seen in dysplasia. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 723. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Female Genital Tract Disease, pp. 467-468. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 209-210.
Question 2: Anaplasia in Wilms' tumor is evident by what features?
- A. Pleomorphic nuclei (Correct Answer)
- B. p53 mutation
- C. Increased cell division
- D. Enlarged nucleus
Explanation: ***Pleomorphic nuclei*** - Anaplastic cells in Wilm's tumor are characterized by **pleomorphic nuclei**, indicating significant variation in size and shape typical of malignancy [1]. - The presence of pleomorphic nuclei suggests loss of **cellular differentiation**, a hallmark of anaplasia [2]. *Increased mitosis* - While increased mitotic figures can indicate a **growing tumor**, it does not specifically denote **anaplasia** itself. - Mitosis can be observed in both benign and malignant lesions, making it a non-specific indicator. *p53 mutation* - Although p53 mutations are associated with many cancers, they are not specific to **anaplastic features** in Wilm's tumor. - Anaplastic histology is defined by nuclear characteristics rather than specific genetic mutations. *Large nucleus* - While anaplastic cells can have large nuclei, the **pleomorphism** in size and shape is more definitive for anaplasia [1]. - Simply having a large nucleus does not necessarily reflect the **abnormal variability** that characterizes anaplasia. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 278. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 276-278.
Question 3: Which of the following is true about Anaplasia?
- A. Benign and fully reversible
- B. Loss of cohesion between cells
- C. Change of epithelium type
- D. Loss of differentiation (Correct Answer)
Explanation: ***Loss of differentiation*** - **Anaplasia** is defined as the loss of structural and functional differentiation in cells, indicating a reversal to a more primitive state [1]. - It is a hallmark feature of **malignancy** and is associated with increased proliferative capacity and aggressiveness of tumors [1]. *Benign and fully reversible* - **Anaplasia** is a characteristic of **malignant tumors** and is generally not reversible without treatment [1]. - Benign cellular changes are typically reversible and maintain their differentiation features [1]. *Loss of cohesion between cells* - While loss of cohesion can occur in some aggressive tumors, it is more specifically related to changes in cell adhesion molecules and is not the primary definition of **anaplasia**. - **Anaplasia** refers to the loss of differentiation, not solely the physical separation of cells [1]. *Change of epithelium type* - This description refers to **metaplasia**, which is the reversible change of one differentiated cell type to another differentiated cell type [1]. - **Anaplasia** involves a loss of differentiation, not merely a change to a different, still differentiated, cell type [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 276-280.
Question 4: Which of the following features on mammogram would suggest malignancy?
- A. Smooth borders
- B. Well defined lesion
- C. A mass of decreased density
- D. Areas of spiculated microcalcifications (Correct Answer)
Explanation: ***Areas of spiculated microcalcifications*** - **Spiculated microcalcifications** are highly suspicious for malignancy due to their irregular shape, distribution, and association with rapid, uncontrolled cell growth. - These calcifications often represent **necrotic cells** within rapidly growing tumors, which can deposit calcium. *Smooth borders* - **Smooth borders** typically indicate a benign lesion, such as a cyst or fibroadenoma, as they suggest gradual, uniform growth rather than invasive spread. - Malignant lesions tend to have **irregular** or ill-defined borders due to their infiltrative nature. *Well defined lesion* - A **well-defined lesion** usually suggests a benign process, as it indicates a mass that is clearly demarcated from surrounding tissue and is likely encapsulated. - Malignancies, conversely, often exhibit **indistinct or irregular margins** as they invade adjacent structures. *A mass of decreased density* - A mass of **decreased density** is generally considered a benign finding, often representing a **cyst** or an area of normal fatty tissue. - Malignant tumors typically present as a **mass of increased density** due to their cellular proliferation and desmoplastic reaction.
Question 5: Which malignancy is characterized by a stepwise progression through lymph nodes, making staging an important prognostic factor?
- A. Hodgkin's lymphoma (Correct Answer)
- B. Multiple myeloma
- C. Mature T cell NHL
- D. Mature B cell NHL
Explanation: ***Hodgkin's lymphoma*** - Characteristically spreads in a **stepwise fashion** through lymphatic pathways [1], making **staging critical** for prognosis [1]. - Its localized dissemination and the presence of **Reed-Sternberg cells** help define its distinct clinical behavior [1]. *Multiple myeloma* - Primarily characterized by **disseminated plasma cell proliferation** and typically does not follow a stepwise spread pattern. - Staging is based on **serum markers** rather than anatomical spread, focusing more on paraproteins and organ damage. *Mature T cell NHL* - Often exhibits an **aggressive** nature with various patterns of spread, but not characteristically in a stepwise manner [2]. - Staging relevance is less focused compared to Hodgkin's lymphoma, as many subtypes present differently. *Mature B cell NHL* - More variable in behavior and can disseminate **discontinuously** [2], lacking a uniform stepwise progression. - Staging exists but is often less straightforward compared to **Hodgkin's lymphoma**, which has a more predictable pattern [1][2].
Question 6: Which of the following stages of lip carcinoma does not have nodal involvement?
- A. T2N1
- B. T3N0 (Correct Answer)
- C. T2N2
- D. T1N1
Explanation: ***T3N0*** - The **'N' classification** in the TNM staging system refers to **nodal involvement**. A stage with **'N0' indicates no regional lymph node metastasis**. - A **T3 lesion** signifies a large primary tumor, but if it's accompanied by **N0**, it means there's no evidence of spread to the lymph nodes. *T2N1* - The **'N1' classification** indicates the presence of **regional lymph node metastasis**, specifically in a **single ipsilateral lymph node** that is 3 cm or less in its greatest dimension. - This stage therefore **does have nodal involvement**, contradicting the premise of the question. *T2N2* - The **'N2' classification** signifies more advanced regional lymph node metastasis, such as a **single ipsilateral lymph node** greater than 3 cm but not more than 6 cm. - It could also refer to **multiple ipsilateral lymph nodes**, none greater than 6 cm, or bilateral/contralateral lymph nodes, none greater than 6 cm. In all these cases, **nodal involvement is present**. *T1N1* - Similar to T2N1, the **'N1' component** in T1N1 indicates the presence of **regional lymph node metastasis** in a single ipsilateral lymph node of 3 cm or less. - Therefore, this stage **does involve nodal spread**, despite having a smaller primary tumor (T1).
Question 7: Which of the following is not a characteristic of malignant lesions?
- A. Absence of encapsulation
- B. Ulcerated borders
- C. Pear-shaped (Correct Answer)
- D. Ill-defined borders
Explanation: ***Pear-shaped*** - A **pear-shaped** morphology is not a typical characteristic of malignant lesions; they usually present with irregular, ill-defined, or infiltrative shapes [1] - This shape is often associated with benign lesions (e.g., fibroadenoma) or specific types of cysts [2] - Malignant tumors characteristically have **irregular, asymmetric, or spiculated** contours [3] *Absence of encapsulation* - Malignant lesions typically lack a well-defined fibrous capsule, allowing them to **invade surrounding tissues** [1] - This characteristic distinguishes them from most benign tumors, which are often encapsulated [2] - The absence of encapsulation is a hallmark feature of malignant behavior *Ulcerated borders* - Ulceration is a common feature of advanced malignant lesions, indicating rapid growth and tissue destruction [3] - This occurs as the tumor outgrows its blood supply or invades superficial layers, leading to tissue breakdown - Surface ulceration is particularly seen in malignant tumors of skin, GI tract, and mucosal surfaces *Ill-defined borders* - Malignant lesions frequently have **irregular or ill-defined borders** due to their invasive and infiltrative growth patterns [2] - This lack of clear demarcation makes complete surgical removal challenging - On imaging and gross examination, poorly defined margins are a key indicator of malignancy **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 276-278. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 280. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 204-206.
Question 8: Which of the following has the least malignant potential?
- A. Hamartomatous polyps associated with Peutz-Jeghers syndrome
- B. Adenomatous polyps associated with Familial adenomatous polyposis
- C. Juvenile polyps associated with juvenile polyposis syndrome (Correct Answer)
- D. Adenomatous polyps associated with Lynch syndrome (HNPCC)
Explanation: ***Juvenile polyps associated with juvenile polyposis syndrome*** - **Isolated juvenile polyps** are benign hamartomas with **minimal intrinsic malignant potential**. - While **juvenile polyposis syndrome (JPS)** as a condition carries an increased lifetime colorectal cancer risk (15-38%), this is primarily due to the development of **co-existing adenomatous polyps** or dysplastic changes, not from the typical juvenile polyp histology itself [1]. - Among the listed options, juvenile polyps have the **least malignant potential**. *Hamartomatous polyps associated with Peutz-Jeghers syndrome* - **Peutz-Jeghers syndrome (PJS)** is characterized by distinctive **hamartomatous polyps** and carries a significantly increased lifetime risk of various cancers, including colorectal, gastric, small intestine, and pancreatic cancers (cumulative risk ~93% by age 70) [1]. - Although hamartomas are benign lesions, these polyps can undergo **malignant transformation** or harbor areas of **adenomatous change and dysplasia**, contributing to the cancer risk [4]. *Adenomatous polyps associated with Familial adenomatous polyposis* - **Familial adenomatous polyposis (FAP)** is caused by a germline mutation in the **APC gene** and is characterized by hundreds to thousands of **adenomatous polyps** in the colon [2]. - Without colectomy, there is a nearly **100% lifetime risk of developing colorectal cancer** due to the malignant transformation of these adenomas [3]. - This represents the **highest malignant potential** among the options. *Adenomatous polyps associated with Lynch syndrome (HNPCC)* - **Lynch syndrome (hereditary nonpolyposis colorectal cancer, HNPCC)** is caused by mutations in DNA mismatch repair genes, leading to an increased risk of various cancers, most notably **colorectal cancer** (lifetime risk 50-80%) [2]. - The polyps associated with Lynch syndrome are typically **adenomatous polyps**, which develop at an earlier age and progress more rapidly to cancer (2-3 years vs 10-15 years for sporadic adenomas) compared to sporadic adenomas [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 813. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 817. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 821-822. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 813-814.
Question 9: Best marker for distinguishing reactive from neoplastic mesothelial proliferation?
- A. Calretinin
- B. WT1
- C. D2-40
- D. BAP1 loss (Correct Answer)
Explanation: ***BAP1 loss*** - Biallelic **BAP1 inactivation**, detected as a loss of nuclear BAP1 immunoreactivity, is a highly specific marker for distinguishing **malignant mesothelioma** from benign reactive mesothelial proliferations. - While other markers confirm mesothelial lineage, only **BAP1 loss** directly points towards malignancy in this context. *Calretinin* - **Calretinin** is a sensitive marker for **mesothelial differentiation**, meaning it is expressed in both reactive and neoplastic mesothelial cells. - Therefore, it cannot differentiate between **benign reactive mesothelium** and **malignant mesothelioma**. *WT1* - **WT1 (Wilms Tumor 1)** is another valuable marker for **mesothelial lineage**, showing nuclear staining in both reactive and neoplastic mesothelial cells. - Like calretinin, its presence indicates mesothelial origin but does not distinguish between **benign and malignant processes**. *D2-40* - **D2-40 (podoplanin)** is a cell surface glycoprotein that is reliably expressed by normal and neoplastic mesothelial cells. - It is used to confirm the **mesothelial nature** of a proliferation but is not specific for malignancy.
Question 10: Regarding parotid neoplasms, the false statement is
- A. FNA has low sensitivity and specificity in diagnosing parotid neoplasms (Correct Answer)
- B. Enucleation leads to recurrence
- C. Pain may be a pointer for malignancy
- D. Deep lobe tumors can present with trismus as early presentation
Explanation: ***FNA has low sensitivity and specificity in diagnosing parotid neoplasms*** - **Fine needle aspiration (FNA)** is actually a highly sensitive and specific diagnostic tool for evaluating parotid gland masses, typically achieving sensitivity and specificity rates of over 90%. - It helps in distinguishing between inflammatory, benign, and malignant lesions with good accuracy, guiding subsequent management. - **This is the FALSE statement** - FNA actually has HIGH sensitivity and specificity. *Deep lobe tumors can present with trismus as early presentation* - **Trismus** (difficulty opening the mouth) is associated with **deep lobe parotid tumors** or tumors that invade adjacent masticator muscles or the pterygoid plates. - Deep lobe tumors can cause trismus when they extend toward or compress the muscles of mastication. - **This is a TRUE statement** - deep lobe involvement can cause trismus. *Enucleation leads to recurrence* - **Enucleation**, which involves simply shelling out the tumor without a cuff of healthy tissue, is associated with a significantly higher recurrence rate for benign parotid tumors, especially **pleomorphic adenomas** (20-45% recurrence). - The standard surgical approach for benign parotid tumors is **superficial parotidectomy** or partial parotidectomy to ensure clear margins and reduce recurrence. - **This is a TRUE statement** - enucleation does increase recurrence risk. *Pain may be a pointer for malignancy* - **Pain** associated with a parotid mass is a concerning symptom and often indicates **malignancy**, especially if it is persistent and progressive. - Benign parotid tumors are typically painless and slow-growing unless they become very large or inflamed. - **This is a TRUE statement** - pain is a red flag for malignancy.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free